SOURCE: Cycle Computing

Cycle Computing

March 03, 2016 09:00 ET

Cycle Computing to Discuss Cloud Computing's Role in the Hunt for Cancer Cell Mutations at Molecular Med Tri-Conference 2016

Cycle CTO Rob Futrick to Detail How Cloud Computing Enabled 15.6 Years of Computation Based Analysis on The Cancer Genome Atlas (TCGA) in Six Months

NEW YORK, NY--(Marketwired - Mar 3, 2016) - Cycle Computing, the leader in cloud computing orchestration software for Big Compute and Big Data, today announced that its Chief Technology Officer, Rob Futrick, will address attendees at the Molecular Med Tri-Conference 2016, to be held March 6-11 at the Moscone North Convention Center in San Francisco. Rob and Cycle Computing are among the 2015 Best Practices Awards competition winners from the 14th Annual Bio-IT World Conference & Expo. Rob has been included in a select group of discussion leaders chosen by the Tri-Conference, because of this past distinction.

Rob will address the Best Practices in Personalized and Translational Medicine course scheduled for Monday, March 7th. His discussion titled, Fighting Cancer Using Cloud to Collaborate & Compute: Gene Fusion Detection Science Project, kicks off the five-pronged course at 8:10 am.

Cycle Computing won the 2015 IT Infrastructure category in the 2015 Best Practices Awards competition at the 14th Annual Bio-IT World Conference & Expo. Cycle and other winners will give attendees at Tri-Conference an in-depth look at cutting edge solutions and techniques for advancing translational medicine research.

Rob will highlight in his discussion how Cycle Computing and a U.S.-based multinational biotechnology company partnered to leverage cloud computing in analyzing The Cancer Genome Atlas (TCGA) data. In the hunt to identify mutations in cancer cells, researchers needed to review 10,000 cancer DNA and RNA samples from TCGA. Cycle software enabled users to quickly, simply, and securely configure and manage large scale clusters and, when the work was completed, consolidate and return results. The research impact was profound and immediate: 15.6 computing years were accomplished in six months; 4,178 tumor samples; 19 cancer types; and 32.2 terabytes of data were processed. Rob's discussion will detail how this work was accomplished and he will share insights for others considering the use of cloud computing in this type of analysis.

Attracting over 3,300 drug discovery and development professionals from over 40 countries in 2015, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics, and Information Technology. With a 23-year history, this year's expanded coverage includes additional programs on Molecular Diagnostics for Infectious Disease, Precision Medicine, and Cancer Immunotherapy, as well as new symposia on Companion Diagnostics and on the Commercialization of Molecular Diagnostics. Attendees will have the opportunity to listen to many of the over-500 speakers from across all industries, all research fields, and from all over the world.

ABOUT CYCLE COMPUTING
Cycle Computing is the leader in cloud computing orchestration software for Big Compute and Big Data. The company believes that greater access to compute enables people to ask bigger questions, obtain faster answers, to help create a better world. Cycle Computing software leverages cloud resources to make computation in the cloud productive at any scale, by orchestrating workflows, managing data, balancing cloud options, and enabling users in a secure, controlled way. Since 2005, Cycle Computing software has been used to deploy virtual clusters and storage for Government, Universities, Fortune 500s, and all sizes of data driven, innovative companies like The Aerospace Corporation, Lockheed Martin, Purdue University, JP Morgan Chase and Pfizer leveraging millions of hours of cloud based computation.

Contact Information

  • Press Inquiries:
    Joanne Hogue
    Smart Connections PR
    410.658.8246
    Email Contact